前列腺腺癌中 68Ga-DOTA-IBA 的偶然摄取。
Incidental Uptake of 68Ga-DOTA-IBA in Prostate Adenocarcinoma.
发表日期：2024 Aug 28
作者：
Huipan Liu, Yuhong Liu, Feifan Xiang, Jianwen Zhang, Yue Chen
来源：
CLINICAL NUCLEAR MEDICINE
摘要：
68Ga 标记的 DOTA-伊班膦酸 (68Ga-DOTA-IBA) 是一种针对骨肿瘤开发的新型 PET 试剂。此外，还报道了非骨性发现中 68Ga-DOTA-IBA 的摄取。在此，我们介绍了原发性前列腺腺癌中 68Ga-DOTA-IBA 摄取的案例。版权所有 © 2024 Wolters Kluwer Health, Inc. 保留所有权利。
68Ga-labeled DOTA-ibandronic acid (68Ga-DOTA-IBA) is a novel PET agent developed for bone tumors. In addition, 68Ga-DOTA-IBA uptake in nonosseous findings has also been reported. Herein, we present a case of 68Ga-DOTA-IBA uptake in primary prostate adenocarcinoma.Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.